For the right patient, Saxenda remains a clinically proven and viable option
GLP-1 user insights: overview Health and side-effects are driving choices Smaller, smarter consumption preference is for bite-sized formats, smaller portions and clearer in-store guidance Overall grocery spend down by 780m Trend set to grow cost is a barrier today, but cheaper GLP-1 pills could accelerate adoption further GLP-1 take-up in Europe has been slower than the US, but its speeding up
The time point was selected at 9:00 prior to NTG injection
Abdominal injections typically provide the fastest and most consistent absorption
Thats a gap patients should be aware of
"I love running, and I never thought I would keep running, but I love it now," says Williams